RelB/p52-mediated NF-kB signaling alters histone acetylation to increase the abundance of corticotropin-releasing hormone in human placenta

Science Signaling

Volumn 8, Issue 391, 2015, Pages ra85-

  Di Stefano, Valeria ^a   Wang, Bingbing ^a   Parobchak, Nataliya ^a   Roche, Natalie ^b   Rosen, Todd ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; HETERODIMER; HISTONE DEACETYLASE 1; HISTONE H3; HISTONE H3 LYSINE 9; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P52; TRANSCRIPTION FACTOR RELB; UNCLASSIFIED DRUG; HDAC1 PROTEIN, HUMAN; HDAC2 PROTEIN, HUMAN; HISTONE; HISTONE DEACETYLASE 2; NFKB2 PROTEIN, HUMAN; RELB PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOTROPHOBLAST; DEACETYLATION; DRUG EXPOSURE; EPIGENETICS; FEMALE; GENE SWITCHING; GESTATIONAL AGE; HISTONE ACETYLATION; HUMAN; PLACENTA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION; ACETYLATION; ADOLESCENT; DRUG EFFECTS; GENETIC EPIGENESIS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PREGNANCY;

ACETYLATION; ADOLESCENT; ADULT; CORTICOTROPIN-RELEASING HORMONE; DEXAMETHASONE; EPIGENESIS, GENETIC; FEMALE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONES; HUMANS; MIDDLE AGED; NF-KAPPA B P52 SUBUNIT; PLACENTA; PREGNANCY; TRANSCRIPTION FACTOR RELB;

EID: 84940383352     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.aaa9806     Document Type: Article

References (36)

1. M. McLean , A. Bisits, J. Davies, R. Woods, P. Lowry, R. Smith, A placental clock controlling the length of human pregnancy. Nat. Med. 1, 460-463 (1995).
2. R. Smith, E. J.Wickings, M. E. Bowman , A. Belleoud, G. Dubreuil, J. J. Davies, G. Madsen, Corticotropin-releasing hormone in chimpanzee and gorilla pregnancies. J. Clin. Endocrinol. Metab. 84, 2820-2825 (1999).
3. P. D. Wadhwa, M. Porto, T. J. Garite, A. Chicz-DeMet, C. A. Sandman,Maternal corticotropinreleasing hormone levels in the early third trimester predict length of gestation in human pregnancy. Am. J. Obstet. Gynecol. 179, 1079-1085 (1998).
4. C. J. Hobel, C. Dunkel-Schetter, S. C. Roesch, L. C. Castro, C. P. Arora, Maternal plasma corticotropin-releasing hormone associated with stress at 20 weeks' gestation in pregnancies ending in preterm delivery. A m. J. Obstet. Gynecol. 180, S257-S263 (1999).
5. W. B. Warren, S. L. Patrick, R. S. Goland, Elevated maternal plasma corticotropinreleasing hormone levels in pregnancies complicated by preterm labor. Am. J. Obstet. Gynecol. 166, 1198-1204 (1992).
6. J. L. Arbiser, C. C. Morton, G. A. Bruns, J. A. Majzoub, Human corticotropin releasing hormone gene is located on the long arm of chromosome 8. Cytogenet. Cell Genet. 47, 113-116 (1988).
7. B. G. Robinson, R. L. Emanuel, D. M. Frim, J. A. Majzoub, Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc. Natl. Acad. Sci. U.S.A. 85, 5244-5248 (1988).
8. B. Wang, N. Parobchak, T. Rosen, RelB/NF-kB2 regulates corticotropin-releasing hormone in the human placenta. Mol. Endocrinol. 26, 1356-1369 (2012).
9. B. Wang, K. Palomares, N. Parobchak, J. Cece, M. Rosen, A. Nguyen, T. Rosen, Glucocorticoid receptor signaling contributes to constitutive activation of the noncanonical NF-kB pathway in t erm human placenta. Mol. Endocrinol. 27, 203-211 (2013).
10. K. Karalis, G. Goodwin, J. A. Majzoub, Cortisol blockade of progesterone: A possible molecular mechanism involved in the initiation of human labor. Nat. Med. 2, 556-560 (1996).
11. B. Wang, N. Parobchak, M. Rosen, N. Roche, T. Rosen, Negative effects of progesterone receptor isoform-A on human placental activity of the noncanonical NF-kB signaling. J. Clin. Endocrinol. Metab. 99, E320-E328 (2014).
12. T. K. Archer, B. J. Deroo, C. J. Fryer, Chromatin modulation of glucocorticoid and progesterone receptor activity. Trends Endocrinol. Metab. 8, 384-390 (1997).
13. S. John, P. J. Sabo, R. E. Thurman, M.-H. Sung, S. C. Biddie, T. A. Johnson, G. L. Hager, J. A. Stamatoyannopoulos, Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat. Genet. 43, 264-268 (2011).
14. F. Wan, M. J. Lenardo, Specification of DNA binding activity of NF-kB proteins. Cold Spring Harb. Perspect. Biol. 1, a000067 (2009).
15. M. Vettese-Dadey, P. A. Grant, T. R. Hebbes, C. Crane-Robinson, C. D. Allis, J. L.Workman, Acetylation of histone H4 plays a primary role in enhancing transcription f actor binding to nucleosomal DNA in vitro. EMBO J. 15, 2508-2518 (1996).
16. Y. Reyes-Dominguez, F. Narendja, H. Berger, A. Gallmetzer, R. Fernandez-Martin, I. Garcia, C. Scazzocchio, J. Strauss, Nucleosome positioning and histone H3 acetylation are independent processes in the Aspergillus nidulans prnD-prnB bidirectional promoter. Eukaryot. Cell 7, 656-663 (2008).
17. V. Morales, H. Richard-Foy, Role of histone N-terminal tails and their acetylation in nucleosome dynamics. Mol. Cell. Biol. 20, 7230-7237 (2000).
18. A. L. Clayton, C. A. Hazzalin, L. C. Mahadevan, Enhanced histone acetylation and transcription: A dynamic perspective. Mol. Cell 23, 289-296 (2006).
19. C. A. Hazzalin, L. C. Mahadevan, Dynamic acetylation of all lysine 4-methylated histone H3 in the mouse nucleus: Analysis at c-fos and c-jun. PLOS Biol. 3, e393 (2005).
20. N. T. Crump, C. A. Hazzalin, E. M. Bowers, R. M. Alani, P. A. Cole, L. C. Mahadevan, Dynamic acetylation of all lysine-4 trimeth ylated histone H3 is evolutionarily conserved and mediated by p300/CBP. Proc. Natl. Acad. Sci. U.S.A. 108, 7814-7819 (2011).
21. S. K. Kurdistani, M. Grunstein, Histone acetylation and deacetylation in yeast. Nat. Rev. Mol. Cell Biol. 4, 276-284 (2003).
22. P. Loidl, Histone acetylation: Facts and questions. Chromosoma 103, 441-449 (1994).
23. S. Panyim, R. Chalk ley, High resolution acrylamide gel electrophoresis of histones. Arch. Biochem. Biophys. 130, 337-346 (1969).
24. C. Abou-Seif, K. L. Shipman, M. Allars, M. H. Norris, Y. X. Chen, R. Smith, R. C. Nicholson, Tissue specific epigenetic differences in CRH gene expression. Front. Biosci. 17, 713-725 (2012).
25. J. R. Challis, D. M. Sloboda, N. Alfaidy, S. J. Lye, W. Gibb, F. A. Patel, W. L. Whittle, J. P. Newnham, Prostaglandins and mechanisms of preterm birth. Reproduction 124, 1-17 (2002).
26. K. Struhl, Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12, 599-606 (1998).
27. L. J. Yu, B. Wang, N. Parobchak, N. Roche, T. Rosen, STAT3 cooperates with the non-canonical NF-kB signaling to regulate pro-labor genes in the human placenta. Placenta 36, 581-586 (2015).
28. J. A. Martin, B. E. Hamilton, S. J. Ventura, M. J. Osterman, T. J. Mathews, Births: Final data for 2011. Natl. Vital Stat. Rep. 62, 1-69 (2013).
29. T. J. Matthews, M. F. MacDorman, Infant mortality statistics from the 2010 period linked birth/infant death data set. Natl. Vital Stat. Rep. 62, 1-26 (2013).
30. M. H. Dyson, S. Rose, L. C. Mahadevan, Acetyllysine-binding and function of bromodomaincontaining proteins in chromatin. Front. Biosci. 6, D853-D865 (2001).
31. A. Loyola, G. Almouzni, Bromodomains in living cells participate in deciphering the histone code. Trends Cell Biol. 14, 279-281 (2004).
32. A. S. Adler, S. Sinha, T. L. Kawahara, J. Y. Zhang, E. Segal, H. Y. Chang, Motif module map reveals enforcement of aging by continual NF-kB activity. Genes Dev. 21, 3244-3257 (2007).
33. F. G. Osorio, C. Lopez-Ot ín, J. M. Freije, NF-kB in premature aging. Aging 4, 726-727 (2012).
34. A. Brunet, S. L. Berger, Epigenetics of aging and aging-related disease. J. Gerontol. A Biol. Sci. Med. Sci. 69 (Suppl. 1), S17-S20 (2014).
35. A. A. Moskalev A. M. Aliper Z. Smit-McBride A. Buzdin A. Zhavoronkov. Genetics and epigenetics of aging and longevity. Cell Cycle 13 1063-1077(2014).
36. D. Shechter, H. L. Dormann, C. D. Allis, S. B. Hake, Extraction, purification and analysis of histones. Nat. Protoc. 2, 1445-1457 (2007).